 |
Contact Us | Ziosoft Japan |
 |
 |
 |
  |
Press ReleasesSince our first year of operation, Ziosoft solutions have proven successful in real world applications. But we didn't stop there. Our industry-leading approach to load balanced distributed processing provides a flexible platform for advancements that maintain the highest workflow and quality standards. Return to this page often to watch as we set new standards in a growing field. 2010Ziosoft Appoints Senior Director of Corporate Communications Yamamura Named President of Ziosoft Japan Ziosoft Promotes Royea to President and COO Ziosoft Launches Significant New Software Upgrade for Ziostation™ System Ziosoft Enters India, Singapore and Malaysia Markets With Ziostation™ System Ziosoft Partners with Insight Oceania to Distribute Ziostation System with PhyZiodynamic Solutions Ziosoft Appoints Brown as New Director of Clinical Solutions Ziosoft to Make PhyZiodynamic™ 5D Functional Analytics U.S. Debut at American College of Cardiology Ziosoft Debuts French and German Translations for Leading Advanced Visualization Software at ECR Ziosoft Introduces PhyZiodynamic™ 5D Functional Analytics Ziosoft Announces the Appointment of Joan Main, Director of Luminary Development 2009Ziosoft Releases Free zioTerm Basic 2D/3D Software Application Ziosoft Announces the Appointment of Rob Royea, Vice President, Sales and Marketing Ziosoft and Global Imaging Online Announce Reseller Agreement for France and Maghreb Area Ziosoft and Healthcare Software Systems Ltd Announce Reseller Agreement for the United Kingdom Ziosoft Releases Latest Version of Its 3D Advanced Visualization Thin-Client Software Ziosoft Receives FDA Clearance for Its MR Cardiac Function Analysis Application Ziosoft Receives CE Marking Approval for Ziostation 3D Thin-Client Advanced Visualization System Ziosoft Debuts New Advanced Visualization Innovations at ITEM 2009 Ziosoft Unveils Advanced Visualization Software Subscription Program Ziosoft Names Bart Hendriks as Managing Director of New International Office Ziosoft Receives FDA Clearance for CT Brain Perfusion Application 2008Ziosoft Inc. Announces Global Marketing Partnership with Medicsight PLC Ziosoft USA Announces Expansion and Relocation to New Facility Ziosoft Announces Launch of Ziostation™ Web Ziosoft to Showcase at 2008 Stanford International MDCT Symposium Ziosoft Names Mark Koeniguer as COO Ziosoft Names Masao Yamamura as Chief Development Officer Ziosoft Names Richard Ball, Director of Regulatory and Quality Affairs 2007Ziosoft's Preview for RSNA 2007 Ziosoft Names Mark Koeniguer Senior Vice President of Business Development Ziosoft USA Announces Expansion and Relocation to New Facility 2006Ziosoft's 3D Medical Imaging Software Showcased with Intel Japan's New Quad-Core Processor ZioSoft Japan has received the 9001:2000 and ISO 13485:2003 Certifications 2010Ziosoft Appoints Senior Director of Corporate CommunicationsHallwyler to Lead Outbound Communications for Supercomputing Functional Visualization PioneerRedwood City, Calif. – June 30, 2010 -- Ziosoft, Inc., a leader in supercomputing, advanced visualization and functional analytics for the medical care market, announced the appointment of Laurie Hallwyler as senior director of Corporate Communications. Hallwyler previously served as a senior communications consultant for the company and has more than 20 years of executive experience in the medical and biotech industries. "Ziosoft's breakthrough supercomputing technology is bringing highly accurate functional visualization to patient care," said Rob Royea, president and COO for Ziosoft. "We need to effectively communicate the numerous clinical, workflow and economical benefits provided by this revolutionary technology. Laurie's extensive experience in medical corporate communications will be an excellent catalyst in this effort." Ziosoft's supercomputing technology is based on dynamic, instantaneous analysis of chaotic information in weather which has extremely similar data characteristics to the human body. Over the years, this technology evolved from a large room of host computer hardware to a centralized, CPU-based processing server allowing multiple concurrent users per server throughout the enterprise system. This has resulted in several significant advantages including non-compressed 3D and 4D images producing the highest integrity and accurate image quality, optimized user efficiency and maximum cost effectiveness for an extensive range of clinical applications. It also enables indications-driven workflow and supports reimbursement as well as HIPAA requirements. "This technology is truly cutting edge, offering state-of-the-art visualization and analytical solutions for increased diagnostic confidence," said Hallwyler. "It is very exciting to hear the enthusiastic feedback we are receiving from leading physicians around the world. I look forward to helping communicate the benefits of Ziosoft's supercomputing technology to additional healthcare professionals and patients alike." Prior to Ziosoft, Hallwyler was vice president of Corporate Communications for Eklin Medical Systems, a leading supplier of digital imaging and image management systems to the veterinary care market. She also held similar positions with R2 Technology (CAD), Zonare Medical Systems and Acuson. Hallwyler has an MBA from the University of Southern California and a BA from the University of Puget Sound. Ziosoft's supercomputing software architecture is economical and scalable, eliminating the need for costly, multiple proprietary or specialized GPU rendering boards. It integrates seamlessly with standard, off-the-shelf hardware and helps expand the life of existing expensive modalities such as CT and MR. About Ziosoft Inc.Founded in 1998, Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit clinicians, patients and healthcare specialists. The company's sophisticated, 3D-5D advanced visualization software provides a wide array of diagnostic tools at any chosen location. With more than 2,000 systems installed worldwide, the Ziostation system from Ziosoft offers state-of-the-art technology to produce superb 3D-5D image quality, helping clinicians to make faster and more confident diagnoses. Ziosoft is a privately held company headquartered in Redwood City, Calif., with offices in Brussels, Belgium and Tokyo, Japan. For further information, visit http://www.ziosoftinc.com. Media Contact:Laurie Hallwyler Yamamura Named President of Ziosoft JapanSupercomputing Visualization Expert Continues Role of Chief Development Officer WorldwideRedwood City, Calif. – June 28, 2010 -- Ziosoft, Inc., a leader in supercomputing, advanced visualization and functional analytics for the medical care market, has named Masao Yamamura president of Ziosoft Japan. Yamamura will also continue in his previous role as chief development officer (CDO) worldwide for the company. "Japan has historically been one of the largest medical imaging markets in the world and a critical market for Ziosoft," said Kazu Matsumoto, founder and CEO of Ziosoft. "Masao has been a key to our success in Japan, helping Ziosoft hold in excess of 60 per cent market share for hospitals with 500 beds and above. We are pleased to have him accept the additional responsibilities of president for Japan and look forward to the company's ongoing success." Yamamura joined Ziosoft in 2007 bringing over 25 years of research and development experience on networked digital imaging systems. He has a demonstrated track record of leading products from planning to development to commercialization. Most recently, he was Senior Vice President and GM at Electronics for Imaging (EFI). Prior to joining EFI, he developed workstations and printing systems for Fuji Xerox and Xerox Corporation. Yamamura holds a BS and MS in Information System Engineering from Hiroshima University, Japan. "The ability to bring my digital imaging network experience to the development of highly accurate functional visualization for the support of improved patient care is extremely gratifying," said Yamamura. "The application of Ziosoft's supercomputing technology to chaotic information produced in the human body brings very powerful solutions to 3D, 4D and, soon to be, 5D functional analytics. I am pleased to help lead our efforts in building upon this revolutionary platform which will continue to provide many exciting new developments for years to come." Ziosoft's supercomputing technology is based on dynamic, instantaneous analysis of chaotic information in weather which has extremely similar data characteristics to the human body. Over the years, this technology evolved from a large room of host computer hardware to a centralized, CPU-based processing server allowing multiple concurrent users per server throughout the enterprise system. This has resulted in several significant advantages including non-compressed 3D and 4D images producing the highest integrity and accurate image quality, optimized user efficiency and maximum cost effectiveness for an extensive range of clinical applications. It also enables indications-driven workflow and supports reimbursement as well as HIPAA requirements. Ziosoft's supercomputing software architecture is economical and scalable, eliminating the need for costly, multiple proprietary or specialized GPU rendering boards. It integrates seamlessly with standard, off-the-shelf hardware and helps expand the life of existing expensive modalities such as CT and MR. About Ziosoft Inc.Founded in 1998, Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit clinicians, patients and healthcare specialists. The company's sophisticated, 3D-5D advanced visualization software provides a wide array of diagnostic tools at any chosen location. With more than 2,000 systems installed worldwide, the Ziostation system from Ziosoft offers state-of-the-art technology to produce superb 3D-5D image quality, helping clinicians to make faster and more confident diagnoses. Ziosoft is a privately held company headquartered in Redwood City, Calif., with offices in Brussels, Belgium and Tokyo, Japan. For further information, visit http://www.ziosoftinc.com. Media Contact:Laurie Hallwyler Ziosoft Promotes Royea to President and COOIndustry Veteran to Lead Growth of Supercomputing Visualization Pioneer in the US, EMEA and Asia Pacific Medical Care MarketsRedwood City, Calif. – June 15, 2010 -- Ziosoft, Inc., a leader in supercomputing, advanced visualization and functional analytics for the medical care market, announced the promotion of Rob Royea to the position of president of Ziosoft U.S., EMEA (Europe, Middle East and Africa) and Asia Pacific (outside of Japan). Royea also will serve as the company's chief operating officer worldwide. Royea previously served as Ziosoft's vice president of sales and marketing. He will continue to lead both of these areas as well. "The U.S. and Europe are two of the largest imaging markets in the world," said Kazu Matsumoto, founder and CEO of Ziosoft. "With the launch of our new Version 2.0 software, we believe our cutting edge supercomputing platform will provide significant and cost effective solutions for advanced visualization and functional analysis of medical images in these markets. Rob's extensive background in medical imaging technology makes him an ideal person to lead the company in addressing the needs of the U.S., EMEA and Asia Pacific." Ziosoft's supercomputing technology is based on dynamic, instantaneous analysis of chaotic information in weather which has extremely similar data characteristics to the human body. Over the years, this technology evolved from a large room of host computer hardware to a centralized, CPU-based processing server allowing multiple concurrent users per server throughout the enterprise system. This has resulted in several significant advantages including non-compressed 3D and 4D images producing the highest integrity and accurate image quality, optimized user efficiency and maximum cost effectiveness for an extensive range of clinical applications. It also enables indications-driven workflow and supports reimbursement as well as HIPAA requirements. "The power of Ziosoft's supercomputing architecture is evident in the superb images it produces," said Royea. "This state-of-the-art foundation harnesses the ongoing growth of computer processing power enabling such advanced solutions as PhyZiodynamics, the gateway to 5D functional analytics. I am excited to be a part of this medical revolution and its impact on the continuum of patient care." Royea has extensive experience as a senior operational, sales and marketing executive with demonstrated success at creating and executing strategies necessary to grow sophisticated medical technology and software companies. Royea previously held executive positions with Eklin Medical Systems, AGFA Healthcare and Siemens Medical Solutions where he had P&L responsibility for more than $550 million in product line revenue. Prior to Siemens, he served in similar positions with Johnson&Johnson and Acuson, helping grow the latter into one of the world's leading ultrasound and ultrasound PACS (Picture Archiving and Communications Systems) companies. Ziosoft's supercomputing software architecture is economical and scalable, eliminating the need for costly, multiple proprietary or specialized GPU rendering boards. It integrates seamlessly with standard, off-the-shelf hardware and helps expand the life of existing expensive modalities such as CT and MR. About Ziosoft Inc.Founded in 1998, Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit clinicians, patients and healthcare specialists. The company's sophisticated, 3D-5D advanced visualization software provides a wide array of diagnostic tools at any chosen location. With more than 2,000 systems installed worldwide, the Ziostation system from Ziosoft offers state-of-the-art technology to produce superb 3D-5D image quality, helping clinicians to make faster and more confident diagnoses. Ziosoft is a privately held company headquartered in Redwood City, Calif., with offices in Brussels, Belgium and Tokyo, Japan. For further information, visit http://www.ziosoftinc.com. Media Contact:Laurie Hallwyler Ziosoft Launches Significant New Software Upgrade for Ziostation™ SystemLeading Developer of Functional Visualization Offers Wealth of Customizable Workflow and Other Clinical EnhancementsRedwood City, Calif. – June 11, 2010 -- Ziosoft, Inc., a leader in advanced visualization and functional analytics for the medical care market, announced the launch of its version 2.0 software upgrade for the Ziostation™ system. The new upgrade features multiple workflow and clinical enhancements including improved colon and vessel analysis with highly customizable protocols. "We worked closely with our clinical research partners to develop additional workflow efficiencies and clinical enhancements," said Kazu Matsumoto, founder and CEO of Ziosoft. "Because our technology is based on a supercomputing software platform, we are able to quickly leverage increases in computer processing power which enables unparalleled image quality and indications-driven workflow as defined by the individual clinician or facility. This newest release is further evidence of the power of supercomputing." The Ziostation v2.0 software upgrade provides automated pre-processing based on user preferences. There are also unlimited protocols that can be configured for any case type to optimize the workflow and user-interface for that specific protocol. Additionally, configurable action "wizards" are available that can simplify processing by offering prompts to step a user through a case. New default buttons and palettes streamline the pathway to clinical outcomes. "We have found the user interface to be even more intuitive and efficient in this new software upgrade," said Myron Pozniak, MD, head of Abdominal Imaging at the Department of Radiology, University of Wisconsin School of Medicine. "The v2.0 release has increased flexibility and numerous workflow enhancements. The customizable protocols contribute significantly to both patient throughput and reaching appropriate, actionable outcomes more quickly." Several clinical enhancements are also available with the upgrade. These include improved colon analysis with multiple layout options and linking tools as well as enhanced vessel analysis. For specific markets outside of the U.S., integration with MedicSight computer aided detection (CAD) for the colon is now available along with SPECT/CT cardiac fusion analysis. MR cardiac time/intensity and delayed signal intensity analysis plus MR brain time/intensity are also provided for these markets. The new 2.0 upgrade was recently featured at the International Society of Computed Tomography conference where Ziosoft participated in a clinical face-off successfully completing all clinical challenges in the allotted four minutes. Ziosoft's supercomputing technology is based on dynamic, instantaneous analysis of chaotic information in weather which has extremely similar data characteristics to the human body. Over the years, this technology evolved from a large room of host computer hardware to a centralized, CPU-based processing server allowing multiple concurrent users throughout the enterprise system. This has resulted in several significant advantages including non-compressed images producing the highest integrity and accurate image quality, optimized user efficiency and maximum cost effectiveness for an extensive range of clinical applications. It also enables indications-driven workflow and supports reimbursement as well as HIPAA requirements. The technology's supercomputing software architecture is economical and scalable, eliminating the need for costly, multiple proprietary or specialized GPU rendering boards. It integrates seamlessly with standard, off-the-shelf hardware and helps expand the life of existing expensive modalities such as CT and MR. About Ziosoft Inc.Founded in 1998, Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit clinicians, patients and healthcare specialists. The company's sophisticated, 3D-5D advanced visualization software provides a wide array of diagnostic tools at any chosen location. With more than 2,000 systems installed worldwide, the Ziostation system from Ziosoft offers state-of-the-art technology to produce superb 3D-5D image quality, helping clinicians to make faster and more confident diagnoses. Ziosoft is a privately held company headquartered in Redwood City, Calif., with offices in Brussels, Belgium and Tokyo, Japan. For further information, visit http://www.ziosoftinc.com. Media Contact:Laurie Hallwyler Ziosoft Enters India, Singapore and Malaysia Markets With Ziostation™ SystemLeading Developer of Supercomputing Functional Visualization Partners with Advanced Medical Systems to Address Needs of Rapidly Growing Healthcare MarketRedwood City, Calif. – May 17, 2010 -- Ziosoft, Inc., a leader in advanced visualization and functional analytics for the medical care market, announced it recently signed a distribution agreement with Advanced Medical Systems (AMS), Pte Ltd., an established Asia/Pacific medical systems & services company headquartered in Singapore. AMS will distribute and support Ziosoft's Ziostation™ system with PhyZiodynamic™ supercomputing technology initially throughout India, Singapore and Malaysia. "Medical device analysts are projecting fairly robust growth in the Asia/Pacific area as the demand for healthcare grows," said Romesh Kaul, president and CEO of AMS. "Recent reports indicate the medical device growth rate will be about 23 percent annually in India alone. We expect the demand for advanced functional visualization to experience similar growth and believe Ziosoft supercomputing technology provides the best choice for 3D, 4D and 5D image data analytics." India will account for 60 percent of heart disease cases worldwide within two years, according to new research by Canadian and Indian researchers published in the Lancet. Cases of cardio vascular disease are expected to hit 65 million annually in India by 2015 (NCMH-Burden of Disease in India-Sept. 2007). "Ziosoft's CT/MR/ANGIO cardiac function analysis software can play a vital role in early and accurate diagnosis to hundreds of these patients. AMS plans to bring Ziosoft's innovative cardiac function analysis products quickly to leading cardiac therapy providers particularly in India," Kaul said. Ziosoft's supercomputing technology was originally applied to dynamic, instantaneous analysis of chaotic information in weather which has extremely similar data characteristics to the human body. Over the years, this technology evolved from a large room of host computer hardware to a centralized, CPU-based processing server allowing multiple concurrent users throughout the enterprise system. This has resulted in several significant advantages including non-compressed images producing the highest integrity and accurate image quality, optimized user efficiency and maximum cost effectiveness for an extensive range of clinical applications. It also enables indications-driven workflow and reimbursement. The technology's supercomputing software architecture is economical and scalable, eliminating the need for costly, multiple proprietary or specialized GPU rendering boards. It integrates seamlessly with standard, off-the-shelf hardware and helps expand the life of existing expensive modalities such as CT and MR. AMS is a medical systems & services organization offering innovative multi-disciplinary solutions for centers of excellence across the Asia Pacific region. It is the only organization of its kind to offer a complete range of services required for facility planning, technology implementation, user training & customer support. The AMS team is highly qualified & industry-experienced with advanced diagnostic imaging and minimally invasive therapy systems in the emerging healthcare marketplace in South Asia, Southeast Asia & Pacific region. "The AMS team is a highly committed and dedicated group of sales, service, engineering and applications specialists," said Rob Royea, vice president of sales and marketing for Ziosoft. "We wanted to partner with an organization that could best represent Ziosoft's commitment to superior patient outcomes. We are pleased to have them as part of our team in working to implement PhyZiodynamic solutions in this emerging market." PhyZiodynamic technology is compatible with any DICOM imaging modality including CT, MR, PET, Nuclear Medicine and Angiography. This allows advanced diagnostic applications for multiple medical specialties such as cardiology, radiology, neurology, orthopedics and oncology. Ziosoft has received regulatory clearance for several clinical applications, including CT brain perfusion, CT coronary analysis and calcium scoring, as well as both MR and CT cardiac function analysis. About Advanced Medical Systems, Pte Ltd.Founded in 1988, Advanced Medical Systems is an established medical devices organization offering innovative multi-disciplinary solutions for centers of excellence across the Asia Pacific region in Radiology, Neurosciences, Orthopedics & Oncology. It is the only organization of its kind to offer a complete range of services required for turnkey facility planning, technology implementation, training, management and finance. Headquartered in Republic of Singapore, AMS directly serves the Asia/Pacific healthcare markets with operating bases & highly trained personnel in Australia, Malaysia, Singapore and India for advanced Imaging and minimally invasive therapy systems and services. For further information, visit www.amssg.com. About Ziosoft Inc.Founded in 1998, Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit clinicians, patients and healthcare specialists. The company's sophisticated, 3D-5D advanced visualization software provides a wide array of diagnostic tools at any chosen location. With more than 2,000 systems installed worldwide, the Ziostation system from Ziosoft offers state-of-the-art technology to produce superb 3D-5D image quality, helping clinicians to make faster and more confident diagnoses. Ziosoft is a privately held company with headquarters in Redwood City, Calif. and offices in Brussels, Belgium and Tokyo, Japan. For further information, visit http://www.ziosoftinc.com. Media Contact:Laurie Hallwyler Aisha Balanay Ziosoft Partners with Insight Oceania to Distribute Ziostation System with PhyZiodynamic SolutionsLeading Developer of 3D, 4D and 5D Supercomputing Functional Visualization Enters Australian and New Zealand Medical MarketsRedwood City, Calif. – May 10, 2010 -- Ziosoft, Inc., a leader in advanced visualization and functional analytics for the medical care market, announced the company has signed a distribution agreement with Insight Oceania, Pty Ltd. (InSight), a major distributor of medical technology in Australasia. InSight will distribute Ziosoft's Ziostation system, including the next generation PhyZiodynamic solutions for the functional visualization and analytics of 3D, 4D and 5D medical images, throughout Australia and New Zealand. "We were amazed by the superb image quality, workflow efficiencies and economics of the Ziostation system," said Andrew McDonald, company director for Insight. "The next generation PhyZiodynamic solutions will take this cutting edge technology to an even higher level, providing the gateway to 5D functional analytics. We believe this could result in substantially improved diagnostic confidence with significant positive impact to patient care." Ziosoft's supercomputing technology was originally applied to dynamic, instantaneous analysis of chaotic information in weather which has extremely similar data characteristics to the human body. Over the years, this technology evolved from a large room of host computer hardware to a centralized, CPU-based processing server allowing multiple concurrent users throughout the enterprise system. This has resulted in several significant advantages including non-compressed images producing the highest integrity and accurate image quality, optimized user efficiency and maximum cost effectiveness for an extensive range of clinical applications. It also enables indications-driven workflow and reimbursement. The technology's supercomputing software architecture is economical and scalable, eliminating the need for costly, multiple proprietary or specialized GPU rendering boards. It integrates seamlessly with standard, off-the-shelf hardware and helps expand the life of existing expensive modalities such as CT and MR. InSight is a recognized leader in the Australasian market providing medical imaging solutions and technical service to its large installed base of high technology medical imaging equipment. InSight has a highly skilled team of clinical and technical specialists together with extensive resources to ensure professional solutions for its customers in hospitals, universities and private clinics throughout the region. "InSight is recognized for offering excellent solutions to its broad base of customers throughout Australasia," said Rob Royea, vice president of sales and marketing for Ziosoft. "The company shares our philosophy in providing outstanding customer service. Together, we look forward to bringing PhyZiodynamic solutions to patient care in the region which will yield appropriate, actionable outcomes." PhyZiodynamic technology is compatible with any DICOM imaging modality including CT, MR, PET, Nuclear Medicine and Angiography. This allows advanced diagnostic applications for multiple medical specialties such as cardiology, radiology, neurology, orthopedics and oncology. Ziosoft has received regulatory clearance for several clinical applications, including CT brain perfusion, CT coronary analysis and calcium scoring, as well as both MR and CT cardiac function analysis. About InSight Oceania, Pty Ltd.Established in Sydney Australia 1998, InSight is the leading medical imaging distribution company in the Oceania region. InSight provides professional sales, service and clinical expertise attaining leading market shares and customer loyalty in niche high-tech medical markets in the region. InSight provides first class clinical solutions and technical service to a large install base of high technology equipment in hospitals, universities and private clinics in Australia and New Zealand. InSight is a wholly owned subsidiary of Quantum Energy Ltd, listed on the Australian Stock Exchange ASX:QTM. For further information, visit www.insight.com.au. About Ziosoft Inc.Founded in 1998, Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit clinicians, patients and healthcare specialists. The company's sophisticated, 3D-5D advanced visualization software provides a wide array of diagnostic tools at any chosen location. With more than 2,000 systems installed worldwide, the Ziostation system from Ziosoft offers state-of-the-art technology to produce superb 3D-5D image quality, helping clinicians to make faster and more confident diagnoses. Ziosoft is a privately held company with locations in Redwood City, Calif., Brussels, Belgium and Tokyo, Japan. For further information, visit http://www.ziosoftinc.com. Media Contact:Laurie Hallwyler John Walstab Ziosoft Appoints Brown as New Director of Clinical SolutionsVolumetric Medical Imaging Education Pioneer Joins Leading Developer of 5D Functional VisualizationRedwood City, Calif. – April 20, 2010 -- Ziosoft, Inc., a leader in advanced visualization and functional analytics for the medical care market, today announced the appointment of Heather Brown, Ph.D. as director of clinical solutions. Brown is responsible for creating the first 3D Advanced Visualization college accredited course in the U.S., which is still being conducted at Jefferson Community & Technical College in Louisville, Kentucky where she is an associate professor. "Dr. Brown brings a wealth of experience in the clinical application of advanced visualization and is considered one of the country's leading educators in this subject," said Rob Royea, vice president of sales and marketing for Ziosoft. "In her new role with Ziosoft, she will work with clients to optimize our highly customizable software for the specific needs of the facility. Additionally, she will serve as a key resource for client research and clinical solutions for applying Ziosoft's supercomputing technology to state-of-the-art patient care." Prior to Ziosoft, Brown held a similar position with 3DR Laboratories in addition to her academic role at Jefferson. She has numerous published research papers including several peer-reviewed articles. Brown earned her bachelor of science degree in mechanical engineering at Michigan Technical University where she graduated cum laude. She later received her master of science and doctoral degrees in biomedical engineering from Vanderbilt University. Brown will also be responsible for assisting customers in implementing Ziosoft's breakthrough PhyZiodynamic solutions. This gateway to 5D functional visualization is based on supercomputing technology originally developed for dynamic, instantaneous weather pattern analysis. Over the years, supercomputing has evolved from a large room of host computer hardware to a centralized, CPU-based processing server allowing multiple concurrent users throughout the enterprise system. This has resulted in several significant advantages including superb image quality, optimized user efficiency and maximum cost effectiveness for an extensive range of clinical applications. The technology offers scalable software solutions, eliminating the need for costly, multiple proprietary or specialized GPU rendering boards. It integrates seamlessly with standard, off-the-shelf hardware and helps expand the life of expensive modalities such as CT and MR. "I have worked with many of today's advanced visualization systems and have found Ziosoft's cutting-edge technology to offer the gold standard in providing measurable, reproducible and dynamic results," said Brown. "When that level of high image quality is combined with a customizable interface, our users can efficiently produce accurate data leading to more appropriate and actionable patient outcomes. I am excited to become a part of the Ziosoft team." PhyZiodynamic technology is compatible with any DICOM imaging modality including CT, MR, PET, Nuclear Medicine and Angiography. This allows advanced diagnostic applications for multiple medical specialties such as cardiology, radiology, neurology, orthopedics and oncology. Ziosoft has received regulatory clearance for several clinical applications, including CT brain perfusion, CT coronary analysis and calcium scoring, as well as both MR and CT cardiac function analysis. About Ziosoft Inc.Founded in 1998, Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit clinicians, patients and healthcare specialists. The company's sophisticated, 3D-5D advanced visualization software provides a wide array of diagnostic tools at any chosen location. With more than 2,000 systems installed worldwide, the Ziostation system from Ziosoft offers state-of-the-art technology to produce superb 3D-5D image quality, helping clinicians to make faster and more confident diagnoses. Ziosoft is a privately held company with locations in Redwood City, Calif., Brussels, Belgium and Tokyo, Japan. For further information, visit http://www.ziosoftinc.com. Media Contact:Laurie Hallwyler Ziosoft to Make PhyZiodynamic™ 5D Functional Analytics U.S. Debut at American College of CardiologyLeader in Advanced Visualization Applies Supercomputing Algorithms to State-of-the-Art Patient CareAtlanta – March 11, 2010 -- Ziosoft, Inc., a leader in advanced visualization and functional analytics for the medical care market, will introduce the company's PhyZiodynamic™ solutions for its Ziostation™ system at the annual American College of Cardiology (ACC) congress being held in Atlanta, March 14 – 16, 2010. PhyZiodynamic technology allows clinicians to automatically apply supercomputing algorithms for the analysis of internal organs, vessels, tumors and other regions of interest in multiple dimensions, from 2D to 5D. "PhyZiodynamic technology provides imaging solutions that are truly remarkable compared to traditional volumetric rendering," said Sung Woo Park, MD, PhD, professor of the Department of Medicine, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine. "When I realized I could clearly see the biomechanics of the papillary muscles, it was apparent there was something very significant here. I believe this technology has the potential to offer a substantial impact on diagnostic speed and accuracy in support of state-of-the-art patient care, especially in cardiology." PhyZiodynamics solutions are based on supercomputing technology originally developed for dynamic, instantaneous weather pattern analysis. Over the years, supercomputing has evolved from a large room of host computer hardware to a centralized, single CPU-based processing server allowing multiple concurrent users throughout the enterprise system. This has resulted in several significant advantages including superb image quality, optimized user efficiency and maximum cost effectiveness for an extensive range of clinical applications. The technology offers scalable software solutions, eliminating the need for costly, multiple proprietary or specialized GPU rendering boards. It integrates seamlessly with standard, off-the-shelf hardware and expands the life of expensive modalities such as CT and MR. "PhyZiodynamic technology provides measurable, reproducible, dynamic outcomes using existing digital modalities already located within the facility thereby expanding their utility and life," said Rob Royea, vice president of sales and marketing for Ziosoft. "Through the application of advanced algorithmic processes, the technology reduces noise without compromising image integrity, allowing the physician to increase diagnostic confidence. It also handles extremely large sets of data on an enterprise basis, rendering images and analysis automatically for greater patient throughput without the need for proprietary or specialized GPU rendering hardware." According to Royea, the key to Ziosoft technology is uncompressed, lossless images which ensure the integrity of all the data at all times. Most importantly, because it is software-based, images are accessible from the office, home or enterprise without the need for proprietary hardware. PhyZiodynamic technology is compatible with any DICOM imaging modality including CT, MR, PET, SPECT and Angio. This allows advanced diagnostic applications for multiple medical specialties such as cardiology, radiology, neurology, orthopedics and oncology. Ziosoft has received regulatory clearance for several applications including CT coronary analysis and calcium scoring, as well as both MR and CT cardiac function analysis. About Ziosoft Inc.Founded in 1998, Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit clinicians, patients and healthcare specialists. The company's sophisticated, 3D-5D advanced visualization software provides a wide array of diagnostic tools at any chosen location. With more than 2,000 systems installed worldwide, the Ziostation system from Ziosoft offers state-of-the-art technology to produce superb 3D-5D image quality, helping clinicians to make faster and more confident diagnoses. Ziosoft is a privately held company with locations in Redwood City, Calif., Brussels, Belgium and Tokyo, Japan. For further information, visit http://www.ziosoftinc.com. Media Contact:Laurie Hallwyler Ziosoft Debuts French and German Translations for Leading Advanced Visualization Software at ECRTranslations Designed to Run on Country-Specific, Standard Operating SystemsVienna – March 8, 2010 -- Ziosoft, Inc., a leader in advanced visualization and functional analytics for the medical care market, will debut both French and German translations of the Company's revolutionary 3D, 4D and 5D functional analytics software at the European Congress of Radiology (ECR) being held in Vienna, March 5-8, 2010. The translations are also designed to run on country-specific, standard operating systems. "We are making a major commitment to the European market as we begin introducing the first of several translations," said Bart Hendriks, managing director of Europe for Ziosoft. "Most importantly, we want to allow seamless integration of our leading visualization software into the facilities existing operating system versus simply translating the language alone. This is uncommon in our market, but we believe it is critical for customer ease-of-use and successful implementation." Ziosoft will be showcasing its Ziostation™ system which is based on PhyZiodynamic™ solutions. Underlying these solutions is supercomputing technology originally developed for dynamic, instantaneous weather pattern analysis. Over the years, supercomputing has evolved from a large room of host computer hardware to a centralized, single CPU-based processing server allowing multiple concurrent users throughout the enterprise system. This has resulted in several significant advantages including superb image quality, optimized user efficiency and maximum cost effectiveness for an extensive range of clinical applications. "Similar to our English version, the French and German Ziostation systems are based on open architecture technology that enable extremely advance applications such as 5D functional analytics," said Hendriks. "Because it is software based without proprietary hardware, our clients can use off-the-shelf hardware and access images or information from anywhere throughout the enterprise system. This enables them to instantaneously apply supercomputing technology to state-of-the-art patient care." Ziosoft technology provides uncompressed, lossless images which ensure the integrity of all the data at all times. PhyZiodynamic technology is compatible with any DICOM imaging modality including CT, MR, PET, SPECT and Angio. This allows advanced diagnostic applications for multiple medical specialties such as radiology, neurology, orthopedics, cardiology and oncology. Ziosoft has received regulatory clearance for several applications including CT brain perfusion, CT coronary analysis and calcium scoring, as well as both MR and CT cardiac function analysis. About Ziosoft Inc.Founded in 1998, Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit clinicians, patients and healthcare specialists. The company's sophisticated, 3D-5D advanced visualization software provides a wide array of diagnostic tools at any chosen location. With more than 2,000 systems installed worldwide, the Ziostation system from Ziosoft offers state-of-the-art technology to produce superb 3D-5D image quality, helping clinicians to make faster and more confident diagnoses. Ziosoft is a privately held company with locations in Redwood City, Calif., Brussels, Belgium and Tokyo, Japan. For further information, visit http://www.ziosoftinc.com. Media Contact:Laurie Hallwyler Ziosoft Introduces PhyZiodynamic™ 5D Functional AnalyticsLeader in Advanced Visualization Applies Supercomputing Algorithms to State-of-the-Art Patient CareVienna – March 4, 2010 -- Ziosoft, Inc., a leader in advanced visualization and functional analytics for the medical care market, will introduce its PhyZiodynamic™ solutions for the Company's Ziostation™ system at the annual European Congress of Radiology (ECR) being held in Vienna, March 5 – 8, 2010. PhyZiodynamic technology allows clinicians to automatically apply supercomputing algorithms for the analysis of internal organs, vessels, tumors and other regions of interest in multiple dimensions, from 2D to 5D. "The high temporal resolution of the post-processed 4D images of the heart allows not only for the functional assessment of ventricular function, but also for atrial function," said Matthias Gutberlet, MD, professor of cardiac radiology, Leipzig Cardiac Center in Germany. "In the near future, this could have an important impact on the evaluation of patients after atrial ablation procedures. For example, the actual course of treatment of atrial fibrillation could be affected based on the information provided to us by this technology." PhyZiodynamics solutions are based on supercomputing technology originally developed for dynamic, instantaneous weather pattern analysis. Over the years, supercomputing has evolved from a large room of host computer hardware to a centralized, single CPU-based processing server allowing multiple concurrent users throughout the enterprise system. This has resulted in several significant advantages including superb image quality, optimized user efficiency and maximum cost effectiveness for an extensive range of clinical applications. The technology offers scalable software solutions, eliminating the need for costly, multiple proprietary or specialized GPU rendering boards. It integrates seamlessly with standard, off-the-shelf hardware and expands the life of expensive modalities such as CT and MR. "PhyZiodynamic technology provides measurable, reproducible, dynamic outcomes using existing digital modalities already located within the facility thereby expanding their utility and life," said Rob Royea, vice president of sales and marketing for Ziosoft. "Through the application of advanced algorithmic processes, the technology reduces noise without compromising image integrity, allowing the physician to increase diagnostic confidence. It also handles extremely large sets of data on an enterprise basis, rendering images and analysis automatically for greater patient throughput without the need for proprietary or specialized GPU rendering hardware." According to Royea, the key to Ziosoft technology is uncompressed, lossless images which ensure the integrity of all the data at all times. Most importantly, because it is software-based, images are accessible from the office, home or enterprise without the need for proprietary hardware. PhyZiodynamic technology is compatible with any DICOM imaging modality including CT, MR, PET, SPECT and Angio. This allows advanced diagnostic applications for multiple medical specialties such as radiology, neurology, orthopedics, cardiology and oncology. Ziosoft has received regulatory clearance for several applications including CT coronary analysis and calcium scoring, as well as both MR and CT cardiac function analysis. About Ziosoft Inc.Founded in 1998, Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit clinicians, patients and healthcare specialists. The company's sophisticated, 3D-5D advanced visualization software provides a wide array of diagnostic tools at any chosen location. With more than 2,000 systems installed worldwide, the Ziostation system from Ziosoft offers state-of-the-art technology to produce superb 3D-5D image quality, helping clinicians to make faster and more confident diagnoses. Ziosoft is a privately held company with locations in Redwood City, Calif., Brussels, Belgium and Tokyo, Japan. For further information, visit http://www.ziosoftinc.com. Media Contact:Laurie Hallwyler Ziosoft Announces the Appointment of Joan Main, Director of Luminary DevelopmentREDWOOD CITY, CA, January 14, 2010 -- Ziosoft®, Inc. a leader in advanced visualization and analysis software for medical imaging, today announced that Joan Main has joined Ziosoft as director of luminary development, effective December 31, 2009. Main brings over 20 years of marketing experience with medical technology products to Ziosoft. Joan has worked in a similar capacity for multiple companies including Johnson and Johnson, Acuson and Siemens Medical Systems. "We are very fortunate to have someone of Joan's caliber joining the Ziosoft team, said Rob Royea, Ziosoft's vice president of sales and marketing. "Through her credible associations with the world's top physicians, Joan has been able to repeatedly help launch new breakthrough technologies from conception, to the number one market share position. Joan has successfully established physician network programs to maximize promotion and market penetration of state-of-the-art technologies and products," Royea stated. In addition to her marketing strengths, Main holds twelve patents, including one for the acquisition and display of 3D ultrasound imaging. She has four additional patents pending. Furthermore, Joan has authored over 20 scientific publications and five scientific abstracts. During her tenure at Acuson, she was the first to introduce color flow imaging to the United States market. Main was most recently employed at Mayo Clinic, Scottsdale, where she had clinical and research responsibilities in the area of early detection of transplant rejection. "I am especially pleased to be joining Ziosoft at this exciting time, as we have an opportunity to develop and introduce compelling new advanced visualization innovations to the market," said Main. "I am particularly impressed with Ziosoft's use of supercomputing algorithms which will allow us to open the world to dynamic visualization resulting in earlier and more advanced clinical diagnostics. I look forward to being an integral part of Ziosoft's success." About Ziosoft Inc.Founded in 1998, Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Ziosoft's sophisticated 3D advanced visualization software offers unlimited diagnostic potential at virtually any location. With over 2,000 systems installed worldwide, the Ziostation thin-client system is revolutionizing the way clinicians access, analyze and share the information required for optimal clinical care. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Media Contact:Betsy Davis, Marketing Communications Manager, Ziosoft 2009Ziosoft Releases Free zioTerm Basic 2D/3D Software ApplicationzioTerm Software will be Offered Initially to the Academic and Research CommunitiesREDWOOD CITY, CA, Nov. 24, 2009 -- Ziosoft®, Inc. a leader in advanced visualization and analysis software for medical imaging, is offering its new zioTerm™ basic 2D/3D software free to the academic and research communities. The Windows®-based software can be used for reviewing DICOM 3.0-compatible imaging data from CT, MR, PET, ultrasound and X-ray on a local computer connected to the internet. This software will provide students and researchers, who often do not have access to quality state of the art imaging tools, the opportunity to gain knowledge and experience using Ziosoft's core 2D/3D software. Ziosoft has been a market leader in 3D advanced visualization software in Japan for over ten years with the Ziostation® system and has recently entered new markets, including the U.S. market. "We believe offering the zioTerm software at no cost is a good way to gain exposure and create brand awareness for Ziosoft and to increase interest in our full featured Ziostation thin-client system," said Terry Chang, Ziosoft director of marketing. "We are pleased to be able to offer this tool to students and researchers who need to learn advanced imaging techniques but are often unable to afford the cost of the 2D/3D software." Although the applications for the Ziostation System have received United States Food and Drug Administration (FDA) clearance for diagnostic use, the zioTerm software is currently intended for educational purposes. zioTerm will eventually be released globally for diagnostic use, in compliance with regulatory bodies worldwide. In the meantime, offering the product to the academic community will help Ziosoft to gain valuable user experience and feedback on the zioTerm software. The zioTerm software can be downloaded from the Ziosoft website: www.ziosoftinc.com. Attendees at the upcoming meeting of the Radiological Society of North America (RSNA) can visit the Ziosoft booth #8353, North Hall, to register for the free zioTerm software and to learn more about Ziosoft's sophisticated 3D advanced visualization tools. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 2,000 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Windows is a trademark of Microsoft corporation. Media Contact:Betsy Davis, Marketing Communications Manager, Ziosoft Ziosoft Announces the Appointment of Rob Royea, Vice President, Sales and MarketingREDWOOD CITY, CA November 18, 2009 -- Ziosoft®, Inc. a leader in advanced visualization and analysis software for medical imaging, today announced that Rob Royea has joined Ziosoft as vice president, sales and marketing, effective November 16. Most recently, Royea served as vice president of worldwide sales for Eklin Medical Systems. Prior to Eklin, Royea held various leadership positions at AGFA Healthcare, Siemens Medical Solutions and Acuson (prior to its acquisition by Siemens). Royea brings over 25 years of experience in diagnostic imaging, PACS and medical informatics companies, ranging from large, global corporations to early stage start-up firms. "Rob's strategic leadership in the U.S., Europe and the Middle East is going to be a great asset to Ziosoft as we move forward in strengthening our position in the marketplace," said Kazuhiko Matsumoto, chief executive officer of Ziosoft. His successful track record and extensive experience in managing global sales and marketing organizations brings a critical capability to Ziosoft and will complement our strategic vision for the company." With highly sophisticated 3D advanced visualization software, Ziosoft offers unlimited diagnostic potential at virtually any location. With over 2,000 systems installed worldwide, the Ziostation thin-client system is revolutionizing the way clinicians access, analyze and share the information required for optimal clinical care. With the Company's end-to-end product integration, every component integrates efficiently, providing industry-leading performance in an economically sensible package. In addition, scalability is central to Ziosoft's product structure. Hospitals are guaranteed long-term investment value with the interoperability of the entire product line while underlying technologies are engineered to scale seamlessly, from one 3D workstation to hundreds. "The ability to provide clinicians with state-of-the-art visualization tools in support of superior patient care is a very exciting opportunity," said Royea. "Ziosoft not only offers superb visualization technology, but also it does so at a very economical performance-to-value ratio. I look forward to working with the Ziosoft team to provide further innovations leading to greater diagnostic confidence." About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 2,000 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Media Contact:Betsy Davis, Marketing Communications Manager, Ziosoft Ziosoft Will Showcase New Clinical Functionality and Workflow Optimization Tools for Its Advanced 3D Thin-Client Software at RSNA 2009New functional imaging applications for the Ziostation System will be unveiled at the RSNA annual meetingRedwood City, CA November 17, 2009 -- Ziosoft®, Inc. a leader in advanced visualization and analysis software for medical imaging will feature its next generation of workflow enhancements and new clinical functionality for the Ziostation® system during the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at Booth #8353 (North Hall). The Ziostation system is based on a highly scalable, true thin-client architecture that requires no proprietary or specialized hardware components. The advanced workflow optimization tools include a customizable user interface, configurable user workflows and anatomy-specific automatic segmentation using Ziosoft's proven, intelligent algorithms. New 3D and 4D applications* that will be previewed include:
* Currently pending regulatory clearance in the US. Also featured at RSNA will be Ziosoft's full suite of FDA-cleared analysis applications including:
The optional Versaweb feature expands the reach of Ziostation's thin-client system to virtually any computer with a web browser and requires no installation of client software, applets or plug-ins. Versaweb provides essential 3D analysis and real-time collaboration tools on a secure website over low bandwidth. Original and saved images as well as reports can be shared by authorized users in real time from a centralized source to optimize the flow of care. Ziosoft will also be offering a free basic 2D/3D software application which has been initially released for use in the U.S. and Canada. RSNA attendees can visit the Ziosoft booth to register for their free software, which is intended for educational use. "We are excited to demonstrate the rapid strides we have made in our product development this year" said Masao Yamamura, Ziosoft's chief development officer. "Our major product enhancements and new applications validate our commitment to providing clinicians with state of the art decision support tools without compromise. RSNA attendees will have the opportunity to learn first-hand why we have been the leading advanced visualization thin-client solution in Japan for over ten years." About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 2000 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Media Contact:Betsy Davis, Marketing Communications Manager, Ziosoft Ziosoft and Global Imaging Online Announce Reseller Agreement for France and Maghreb AreaGlobal Imaging Online will introduce the Ziostation® 3D advanced visualization software to the French market as an integrated productMontreuil (93) – France – October 1st 2009 -- Ziosoft®, Inc. a leader in advanced visualization and analysis software for medical imaging and Global Imaging Online, French leader of PACS, RIS and Tele-Radiology solutions, announced today that the companies have signed an agreement for Global Imaging Online to distribute advanced 3D thin-client software solutions in France. The Ziostation system integrates seamlessly with the Global Imaging Online PACS solutions – DIAM4 servers. The Ziostation solution provides advanced visualization tools including CT and MR cardiac function analysis, calcium scoring, CT brain perfusion, advanced vessel analysis, colon analysis and multi-modality fusion analysis. "I am excited about introducing Ziosoft's 3D thin-client software in France "said Rainer Kabouya, new CEO of Global Imaging Online. "The breadth of products Ziosoft offers, the enterprise wide architecture and the exceptional system performance is a great complement to the current solutions of Global Imaging Online, and a major interest to the French radiology community. It will be a great addition for Global Imaging Online to the Tele-radiology solutions introduced in January 2009 with Expertise Radiologie partnership. I invite all French radiologists to come during the JFR congress – 16-20 Oct – Paris, to our booth (N° 1P05 – Hall 1) to have a demonstration of the advanced Ziosoft 3D applications." "We are pleased to be partnering with this proven and trusted Company that will enable us to offer Ziosoft's products to radiologists and French clinicians, many of whom already recognize the capabilities of Global Imaging Online – more than 350 French sites are using DIAM4 PACS" said Bart Hendriks, Ziosoft's managing director for Europe, Middle East and Africa. "We will be able to offer French customers an outstanding 3D thin-client product combined with the exceptional service and support of Global Imaging Online." About Global Imaging OnlineGlobal Imaging Online Company is a recognized leader in PACS, RIS and Tele-Expertise solution in France. Founded in 1999, Global Imaging Online is a leading independent with over 350 sites. Global Imaging Online development strategy is to increase its solutions – DIAM product family – on treatments, medical image management and communication. All DIAM solutions are WEB based. For more information please visit: http://www.global-imaging.net About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 2000 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Media Contact U.S.:Betsy Davis, Marketing Communications Manager Media Contact French – GIOL :J-Yves AMATHIEU, Mktg Manager Ziosoft and Healthcare Software Systems Ltd Announce Reseller Agreement for the United KingdomHealthcare Software Systems will introduce the Ziostation® 3D thin-client system to the UK marketRedwood City, CA. August 6, 2009 -- Ziosoft®, Inc. a leader in advanced visualization and analysis software for medical imaging and Healthcare Software Systems Ltd. (HSS) the UK's leading supplier of radiology information systems, announced today that the companies have signed an agreement for HSS to distribute Ziosoft's 3D thin-client software solutions in the UK. HSS supplies and supports the UK's leading radiology information system (CRIS). The Ziostation system integrates seamlessly with the CRIS radiology information system and can process images from all PACS systems. The Ziostation solution provides advanced visualization tools including CT and MR cardiac function analysis, calcium scoring, CT brain perfusion, advanced vessel analysis, colon analysis and multi-modality fusion analysis. "I am excited about introducing Ziosoft's 3D thin-client software in the UK, "said Nikolas Solomon, director of HSS. ""The breadth of products Ziosoft offers, the enterprise wide architecture and the exceptional system performance is of great interest to the UK radiology community." "We are pleased to be partnering with this proven and trusted Company that will enable us to offer Ziosoft's products to UK clinicians, many of whom already recognize the capabilities of HSS" said Bart Hendriks, Ziosoft's managing director for Europe, Middle East and Africa. "We will be able to offer UK customers an outstanding 3D thin-client product combined with the exceptional service and support of HSS." About Healthcare Software Systems LtdHealthcare Software Systems Ltd. (HSS), founded in 1984, is the UK's leading supplier of Radiology Information Systems. HSS has installations at over 175 sites nationwide and over 25 years experience of designing, implementing and supporting hospital based information systems. For more information please visit: http://www.hssnet.com. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 1800 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Media Contact U.S.:Betsy Davis, Marketing Communications Manager Media Contact UK:Nikolas Solomon, Director HSS Ziosoft Releases Latest Version of Its 3D Advanced Visualization Thin-Client SoftwareMajor Release Delivers New Cardiac Features and Enhancements to Existing ToolsRedwood City, CA, July 22, 2009 -- Ziosoft®, Inc. a leader in advanced visualization and analysis software for medical imaging today announced that it has released the latest version of its 3D thin-client software for shipment worldwide. This release delivers new applications such as MR cardiac function analysis, as well as reporting and workflow enhancements. In addition, the CT cardiac function and calcium scoring applications recently cleared by the United States Food and Drug Administration (FDA) are included as part of this release. All of the applications in the new release are accessible on a thin-client system. Ziosoft recently received CE marking approval for its Ziostation® 3D thin-client software system which allows the company to market the product to countries of the European Union. Additionally, the company has just begun releasing the new software to customer sites in Japan. "I am very excited about this major release which expands the already robust Ziostation® feature set with major CT and MR cardiac function software to aid the clinician in improving diagnosis" said Masao Yamamura, Ziosoft's chief development officer. "Moreover, we have validated this software version on the latest, most powerful standard commercial hardware to improve users' workflow and efficiency." This marks Ziosoft's second major software release during 2009. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 1800 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Contact:Betsy Davis, Marketing Communications Manager Ziosoft Receives FDA Clearance for Its MR Cardiac Function Analysis ApplicationCardiac MR Module Expands the Clinical Value of the Ziostation® Thin-Client Advanced Visualization SystemRedwood City, Calif. July 8, 2009 -- Ziosoft®, Inc., a leader in advanced visualization and analysis software for medical imaging, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its magnetic resonance (MR) cardiac function analysis application for use with the Ziostation® thin-client system. The MR cardiac function analysis application is used by physicians to evaluate the structures and function of the heart in the initial screening and subsequent management of coronary disease patients. Ziosoft's MR cardiac function application provides physicians with the unique capability to extract left ventricle myocardial contours from Ziosoft's automatic interpolation algorithm to obtain highly accurate results. In addition to the standard functional assessment calculations such as ejection fraction, peak filling rate (PFR) and peak ejection rate (PER), automatic calculation of myocardial mass is also generated with the Ziosoft application. The software provides the capability to automatically produce "bull's eye" representations as well as a time volume graph to aid in the patient evaluation. Ziosoft's application has the ability to display different sequences in one view, allowing clinicians to scroll between sequences and positions simultaneously. This exclusive feature provides an intuitive method of displaying patient information for more proficient image interpretation. The MR cardiac function application can be accessed throughout the enterprise on the Ziostation thin-client system to provide physicians with improved efficiency and real-time collaboration when assessing results from an MR study. MR has advanced over the years to provide outstanding image quality while maintaining a non-ionizing means of image acquisition. "Ziosoft is proud to offer a cardiac MR functional module which provides physicians with another option for assessing cardiac function, "said Mark Koeniguer, Ziosoft's chief operating officer. "This latest application offers significant enhancements to our cardiac offering and provides physicians with state of the art tools to improve patient outcomes." About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 1800 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Contact:Betsy Davis, Marketing Communications Manager Ziosoft Receives CE Marking Approval for Ziostation 3D Thin-Client Advanced Visualization SystemApproval will allow Ziosoft to market its software solutions throughout EuropeRedwood City, CA, July 1, 2009 -- Ziosoft®, Inc. Inc. a leader in advanced visualization and analysis software for medical imaging, today announced that it has received CE marking approval for its Ziostation 3D thin-client software system. CE marking approval allows Ziosoft to market its software solutions to the 27 countries in the European Union (EU) as well as the countries of the European Economic Area (EEA) which includes the countries of the European Free Trade Association (EFTA). In anticipation of this approval, Ziosoft recently established a European headquarters in Brussels, Belgium and has formed a number of strategic alliances with partners and distributors throughout Europe. "CE marking approval is an important step in our strategy to broaden Ziosoft's position in the international market", said Bart Hendriks, Ziosoft's managing director for Europe, Middle East and Africa. "We believe Europe will be a significant area of growth for Ziosoft's thin-client advanced visualization software." Ziosoft is the market leader in Japan since its founding there in 1998. In 2008 Ziosoft entered the U.S. market and has received a number of United States Food and Drug Administration (FDA) clearances for its software applications. Ziosoft is also in the process of registering the Ziostation system in Canada in line with the company strategy to provide global access to Ziosoft's innovative software solutions. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 1800 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Contact:Betsy Davis, Marketing Communications Manager Ziosoft 3D Thin-Client Software Gives Impressive Performance at Stanford MDCT Conference Workstation Face-OffZiosoft Is Outstanding in First-Time Appearance at the Workstation Face-Off during Stanford Conference on Multi-Detector Row CTRedwood City, CA, May 27, 2009 -- Ziosoft®, Inc. a leader in advanced visualization and analysis software for medical imaging was a first time participant in the Stanford Workstation Face-Off, during the 11th Annual Symposium on Multidetector Row CT held last week in San Francisco. The 7th annual Workstation Face-Off challenged the eight participating 3D advanced imaging providers to load, process and interpret five computed tomography (CT) studies within an allotted period of time, which varied from two to four minutes per case. Dr. Jeffrey Mendel, of Tufts University School of Medicine, demonstrated the Ziosoft software applications and was able to showcase the ease of use of the Ziosoft system by completing all five CT cases effortlessly within the time allotted. "As a new user to the Ziostation thin-client software applications, I was able to quickly learn the software. I am impressed by the quality of the images, the efficiency of the software and the powerful advanced applications that Ziosoft offers" said Dr. Mendel. Ziosoft's Ziostation system utilized a true thin-client application with CPU-based processing. The Ziostation did not require any proprietary or specialized hardware unlike some of the other advanced visualization solutions. "We are delighted that conference attendees were able to see a comparison of our software applications and image quality side by side with seven of our competitors. We believe the strong showing by Ziosoft is an indication of the quality of our software solutions which have made us a market leader for over ten years" said Mark Koeniguer, Ziosoft's chief operations officer. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 1800 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Contact:Betsy Davis, Marketing Communications Manager Ziosoft and MMS Medicor Medical Supplies GmbH Kerpen Announce Partnership Agreement for Germany, Austria and SwitzerlandCompanies Will Showcase New Collaboration at German Radiology Conference (DRK) in Berlin, May 20-23, 2009Berlin, Germany, May 21, 2009 -- Ziosoft®, Inc., a leader in advanced visualization and analysis software for medical imaging and MMS Medicor Medical Supplies GmbH Kerpen (Medicor), a leading distributor of medical products in Europe, announced today that the companies have signed an exclusive agreement for Medicor to distribute Ziosoft's 3D thin-client software solutions in Germany, Austria and Switzerland. For the cardiology market, Medicor's affiliate, Corizon GmbH, will distribute and service Ziosoft's products in these countries. To launch this new partnership, Ziosoft will be displaying their thin-client software solutions in the Medicor booths ( A 17 and A 19) at the German Radiology Conference in Berlin May 20-23. "We are very pleased with the partnership with MMS Medicor" said Bart Hendriks, Ziosoft's managing director for Europe, Middle East and Africa. "As a highly-respected market leader, MMS Medicor is the perfect healthcare partner to deliver our Ziosoft next generation 3D advanced visualization solutions to the markets in Germany, Austria and Switzerland." "We are honored to represent this knowledgeable and capable brand name in 3D thin-client solutions, said Heinz Gerhards, Medicor's managing director. "The Ziosoft collaboration is a logical alliance for Medicor's portfolio and will better serve not only our existing customers but will allow us to reach new customers with the excellent Ziosoft products." About MMS Medicor Medical Supplies GmbH KerpenMMS Medicor Medical Supplies GmbH Kerpen, (Medicor) founded in 1992, is the established leader for service and medical device distribution of radiology equipment and the leading distributor of women's healthcare products in Germany. Medicor's portfolio consists of a wide range of products for radiology, cardiology, and surgery as well as serving distributorships in the fields of diagnostics and intervention. Medicor is committed to providing excellent service and application capabilities and has more than 20 applications, service and field engineers throughout Germany. Medicor is headquartered in Germany with offices throughout Europe. For more information, please visit http://medicor.de About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 1800 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Contact:Betsy Davis, Marketing Communications Manager Ziosoft Debuts New Advanced Visualization Innovations at ITEM 2009Over 2,500 attendees visit Ziosoft's booth during Japan's largest radiology conferenceRedwood City, CA. April 23, 2009 -- Ziosoft®, Inc., a leader in advanced visualization and analysis software recently showcased its latest innovations for the Ziostation® thin client system at the International Technical Exhibition of Medical Imaging (ITEM) held April 17-19 in Yokohama, Japan. Highlights of the Ziosoft exhibit included a new SPECT/CT fusion application, MR cardiac function analysis and 4D brain perfusion showing dynamic analysis using images from a 320-slice CT scanner.* Also featured was a "fine grained" load balancing concept for server clustering as well as the new zioTerm free 2D and pay-per-study 3D application model targeted towards academic users. The power of Ziostation's accessibility was further demonstrated using its recently released VersaWeb™ and proof of concept iPhone applications. Ziosoft also presented a luncheon seminar with talks by Dr. Yasuyuki Kobayashi, St. Marianna University and Dr. Makoto Sasaki, Iwate Medical University. Dr. Kobayashi's topic was cardiac function quantitative analysis that included research he conducted with Ziosoft as a fellow at Johns Hopkins University. Dr. Sasaki addressed current and future brain perfusion assessment technologies. "The response to our new technology was overwhelming" said Kazuhiko Matsumoto, Ziosoft chief executive officer. "For more than a decade we have been developing advanced visualization tools for the clinician and the positive reaction to our latest innovations is very rewarding." *These products not currently cleared for sale in the United States About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is the leading independent advanced visualization company in Japan with over 1800 installed systems. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Contact:Betsy Davis, Marketing Communications Manager Ziosoft Receives FDA Clearance for CT Cardiac Function Analysis and Cardiac Calcium Scoring ApplicationsAdditional Cardiac Applications Expand the Clinical Utility of the Ziostation® Thin-Client Advanced Visualization SystemRedwood City, CA, April 7, 2009 -- Ziosoft®, Inc., a leader in advanced visualization and analysis software for medical imaging, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market two additional applications for use with the Ziostation thin-client system. These applications enhance the productivity and diagnostic capability of physicians when evaluating patients' heart health. Both the cardiac function analysis and calcium scoring applications can be accessed throughout the enterprise on the Ziostation thin-client system to provide physicians with improved efficiency and real-time collaboration when assessing results from a CT cardiac scan. The calcium scoring application is used by physicians to help determine whether a patient may be at increased risk for coronary artery disease. Ziosoft's calcium scoring application features valuable tools for the clinician such as concurrent reading of the calcium analysis adjacent to the original data set, which allows for efficient and precise analysis of data. The cardiac function application enables physicians to conduct a cardiac functional assessment and includes Ziosoft's unique tools such as automatic left ventricle segmentation, peak filling rate (PFR) and peak ejection rate (PER) in addition to the standard functional assessment calculations. The cardiac function application also includes the capability to automatically generate "bulls-eye" maps and a time volume graph to aid in the physician's evaluation. According to the National Center for Health Statistics (NCHS) every year since 1900, except 1918, cardiovascular disease accounted for more deaths than any other single cause or group of causes of death in the United States. Nearly 2,400 Americans die of cardiovascular disease each day, an average of one death every 37 seconds. These new applications from Ziosoft will contribute to more efficient interpretation and improved communication of test results, leading to enhanced quality of care for patients. "We are proud of our long history of developing software applications which aid physicians in evaluating diseases" said Kazuhiko Matsumoto, Ziosoft's chief executive officer. "These latest applications will be added to Ziosoft's suite of applications for a robust cardiac tool set for the market." About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is the leading independent advanced visualization company in Japan with over 1800 installed systems. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Contact:Betsy Davis, Marketing Communications Manager Ziosoft Unveils Advanced Visualization Software Subscription ProgramCompany will offer flexible purchasing plans tailored to customers' needsRedwood City, CA, March 9, 2009 -- Ziosoft, a leader in thin-client advanced visualization and analysis software for medical imaging today announced a new monthly subscription program for its Ziostation® software. Under this program, facilities will be able to utilize Ziosoft's thin-client system immediately without a capital investment. "Our physicians realize the benefit our 3D advanced visualization tools bring to patient diagnosis and care, but in this challenging economy capital expenditure has been restricted" said Mark Koeniguer, Ziosoft's chief operating officer. "In response to customer requests, we have created a number of flexible purchasing options, including a monthly subscription fee program. This program will allow physicians the access they need to 3D advanced visualization tools without compromising capital budgets." Ziosoft's advanced visualization software reconstructs large image data sets acquired from CT and MR systems into interactive 3D images over a unified thin-client configuration. Physicians are able to interact with these images for a more efficient and accurate diagnosis. The reach of 3D advanced visualization, once used primarily by radiologists, has been extended to surgeons, cardiologists, oncologists and referring physicians and has become a valuable tool across the enterprise. Facilities that have been waiting to purchase 3D analysis software until budgets permit, will now have immediate access to these valuable imaging tools with the new Ziosoft subscription fee option. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is the leading independent advanced visualization company in Japan with over 1800 installed systems. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft is a registered trademark of Ziosoft Inc. Contact:Betsy Davis, Marketing Communications Manager Ziosoft Names Bart Hendriks as Managing Director of New International OfficeMr. Hendriks will have responsibility for Europe, Middle East and Africa operationsRedwood City, CA, March 2, 2009 -- Ziosoft®, a leader in advanced visualization and analysis software for medical imaging today announced the appointment of Bart Hendriks as managing director for Europe, Middle East and Africa for Ziosoft International, a new office based in Brussels, Belgium. In his new position, Bart Hendriks will be responsible for Ziosoft's business strategy, business development and sales for the company's expansion into new markets in Europe, the Middle East and Africa. Mr. Hendriks brings over 19 years of global sales, marketing, operations and financial expertise in the healthcare and IT software and hardware industries. He has a successful track record in leadership positions with both emerging and established companies. Mr. Hendriks' international experience includes Europe, the United States, China and India. "Bart Hendriks' in-depth experience and knowledge of the international healthcare industry will be instrumental as we expand into new markets" said Mark Koeniguer, Ziosoft chief operating officer. "Additionally, Mr. Hendriks' technical background and experience in advanced visualization and PACS environments will position Ziosoft well as our operations develop internationally." Bart Hendriks will attend the European debut of the Ziosoft technology at the European Congress of Radiology at Ziosoft's booth, 586, Expo E, March 6-9 in Vienna, Austria. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is the leading independent advanced visualization company in Japan with over 1800 installed systems. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Contact:Betsy Davis, Marketing Communications Manager Ziosoft Receives FDA Clearance for CT Brain Perfusion ApplicationBrain perfusion application is accessible to clinicians throughout the enterprise using the Ziostation® thin-client systemRedwood City, Calif. January 6, 2009 -- Ziosoft®, Inc., a leader in advanced visualization and analysis software for medical imaging, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its CT brain perfusion application. The brain perfusion application is a powerful analysis tool used with the Ziostation thin-client system. The software is unique in its ability to provide brain perfusion functionality to clinicians as a thin-client application using standard commercial hardware. This software option aids radiologists in stroke assessment by providing a color map of cerebral blood flow and other perfusion-related parameters from CT images of the brain. The brain perfusion application includes image manipulation tools as well as measurement tools such as cerebral blood volume, blood flow and mean transit time. Ziosoft's brain perfusion application provides radiologists with decision support tools to accurately assess the type and extent of cerebral perfusion disturbance whether viewed in a hospital or at a remote location offering physicians flexibility and efficiency in viewing solutions. "Because time to reach diagnosis and begin treatment for stroke victims is critical, we are pleased to provide this new brain perfusion application which can be accessed enterprise-wide, said Mark Koeniguer, Ziosoft's chief operating officer. "Results can also be accessed via a standard web-browser through Ziostation VersaWeb™, demonstrating our commitment to providing clinicians with the most advanced imaging software wherever needed." About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is the leading independent advanced visualization company in Japan with over 1800 installed systems. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Contact:Betsy Davis, Marketing Communications Manager 2008Ziosoft Inc. Announces Global Marketing Partnership with Medicsight PLCRedwood City, CA. / London, UK, November 25, 2008 -- Ziosoft®, Inc., a leader in advanced visualization and analysis software for medical imaging, today announced a partnership with Medicsight PLC to market the company's Computer-Aided Detection (CAD) software integrated within the Ziostation® thin-client 3D system. The combined CT-Colonography product is expected to be launched early 2009 upon regulatory clearance in the US. The proof-of-concept integration will be demonstrated in the Ziosoft booth #7957 at the forthcoming 94th Scientific Assembly and Annual Meeting of the Radiology Society of North America (RSNA), being held in Chicago, November 30 through December 5, 2008. "We are unique in our ability to provide full colon analysis on a thin-client platform without the need for a supplementary standalone workstation," said Mark Koeniguer, chief operating officer for Ziosoft. "By integrating Medicsight's ColonCAD with our revolutionary 3D imaging applications, our customers will reap the full benefits of a comprehensive colon analysis toolset throughout their healthcare enterprise." David Sumner, Chief Executive of Medicsight, said: "We are proud to be partnering with one of the leading advanced visualization companies in the world. We're confident our combined intelligent technologies will increase clinical value for our users." About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is the leading independent advanced visualization company in Japan with over 1500 installed systems. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA and Tokyo, Japan. For more information, visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Contact:Betsy Davis Ziosoft USA Announces Expansion and Relocation to New FacilityRedwood City, Calif. November 17, 2008 -- Ziosoft, Inc., a leader in advanced visualization and analysis software for medical imaging, today announced the relocation of its US office to meet the rapid growth and future demands of its operations. The new, larger office is located at 1000 Bridge Parkway, Suite #100, Redwood City, CA. 94065. "We are excited to move into a new state-of-the-art facility that triples our existing physical space," said Mark Koeniguer, chief operating officer for Ziosoft. "Our staff in the US has quadrupled in two years as we increase our sales and development activities. This new facility will provide us room for continued growth and allow us to better serve our customers." About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is the leading independent advanced visualization company in Japan with over 1500 installed systems. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA and Tokyo, Japan. For more information, visit http://www.ziosoftinc.com. Ziosoft is a registered trademark of Ziosoft Inc. Contact:Terry Chang, Director of Marketing Ziosoft Announces Launch of Ziostation™ WebAdvanced visualization innovations for the Ziostation system will be unveiled at RSNA 2008.Redwood City, Calif. November 13, 2008 -- Ziosoft, Inc., a leader in advanced visualization and analysis software for medical imaging, will debut its new Ziostation VersaWeb™ (v3.0) at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at Booth #7957 (North Hall). The Ziostation Web expands the reach of Ziosoft's revolutionary Ziostation thin-client 3D system to virtually any computer with a web browser and requires no installation of client software or plug-ins. Ziostation Web provides essential 3D analysis and real-time collaboration tools on a secure website without the need for any proprietary or specialized hardware. Original and saved images as well as reports can be shared by authorized users from a centralized source to optimize the flow of care. "Ziostation VersaWeb™ takes our powerful thin-client 3D system to a new dimension" said Ziosoft chief operating officer Mark Koeniguer. "Clinicians have the need to view and interact with 3D images at a moment's notice wherever they may be. The Ziostation VersaWeb™ removes the barriers of accessibility while maintaining performance and image integrity." The Ziostation system is based on a highly scalable, unified thin-client architecture that requires no proprietary or specialized hardware components. The Ziostation also has the ability to load-balance case processing and does not necessitate a separate standalone workstation to supplement its functionality. In addition to Ziostation VersaWeb™, other advanced features of the Ziostation system that will be demonstrated at RSNA include:
"We are excited to demonstrate our latest innovations at this year's RSNA," said Ziosoft director of marketing, Terry Chang. "User needs for advanced visualization and analysis have changed over the past 10 years but existing solutions have not kept pace. The Ziostation system addresses the changing needs by providing clinicians access to sophisticated and powerful tools whether inside or outside the workplace without sacrificing performance." About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is the leading independent advanced visualization company in Japan with over 1500 installed systems. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com. Ziosoft and Ziostation are registered trademarks of Ziosoft Inc. Contact:Terry Chang, Director of Marketing Ziosoft, Inc. and Johns Hopkins University School of Medicine Announce Partnership Agreement for Advanced VisualizationRedwood City, CA, June 16, 2008 --- Ziosoft Inc., a leader in advanced visualization and analysis software for medical imaging, announced today that it is partnering with one of the world's most prestigious medical teaching institutions, Johns Hopkins University, to explore innovative applications for cardiac CT and MR imaging. Under terms of the agreement, Johns Hopkins University, under the direction of Joao Lima, M.D., Professor of Medicine and Director of Cardiovascular Imaging in Cardiology at the Johns Hopkins School of Medicine, will utilize Ziosoft's ZIOSTATION 3D/4D enterprise software to develop next-generation applications for coronary and cardiac analysis. "We are honored to be collaborating with Johns Hopkins University to expand the uses of advanced visualization in cardiovascular imaging," said Ziosoft Chief Executive Officer Kazuhiko Matsumoto. "This important partnership will help ensure that advanced visualization software will continue to enable the full technical and clinical potential of CT and MR. We will be working together to develop promising concepts with benefits for both the patient and the enterprise healthcare system." "We are very eager to partner with Ziosoft in several areas of scientific development related to CT and MR cardiovascular imaging," said Dr. Lima. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA and Tokyo, Japan. For more information, visit http://www.ziosoftinc.com. About Johns HopkinsJohns Hopkins Hospital is a recognized leader in cardiovascular imaging and software development featured prominently as part of the Institutions mission to improve patient care and generate knowledge in Cardiovascular Medicine. Ziosoft to Showcase at 2008 Stanford International MDCT SymposiumRedwood City, CA, May 12, 2008 --- Ziosoft Inc., a leader in volumetric medical imaging software, will be showcasing the FDA-cleared ZIOSTATION 3D visualization and analysis software in Booth #20 at this year's Stanford International MDCT Symposium in Las Vegas, NV. The ZIOSTATION provides advanced volumetric imaging tools using thin client software to quickly access, analyze, and share the information required for the best patient care. Intelligent clinical tools include automatic segmentation, multi-volume fusion, and coronary analysis. A customizable user-interface and flexible action macros further simplifies the user experience. The ZIOSTATION's full range of scalable configurations supports critical functions for both physicians and technologists. With end-to-end product integration, every software and non-proprietary hardware component integrates efficiently. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked volumetric medical imaging and analysis software to benefit physicians, patients, and healthcare specialists. Ziosoft is dedicated to providing advanced intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA and Tokyo, Japan. For more information, visit http://www.ziosoftinc.com. Ziosoft Names Mark Koeniguer as COORedwood City, CA, May 1, 2008 --- Mark A. Koeniguer has been appointed Chief Operating Officer (COO) for Ziosoft, Inc., a leader in advanced visualization and analysis software for medical imaging. In his expanded position, Koeniguer will be responsible for Ziosoft's sales, marketing, business development, and operations for the US and Europe. Koeniguer brings over 18 years of sales, marketing, and general management experience with both emerging and established companies in the healthcare industry. Most recently, he was Global Vice President of Sales for R2 Technology, Inc. prior to its acquisition by Hologic in 2006. Prior to joining R2, he held leadership positions for Stereotaxis, Inc. and GE Healthcare. Mark Koeniguer holds a BS with a major in Finance from the University of Iowa and a MBA from the University of Wisconsin – Madison. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked volumetric medical imaging and analysis software to benefit physicians, patients, and healthcare specialists. Ziosoft is dedicated to providing advanced intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA and Tokyo, Japan. For more information, visit http://www.ziosoftinc.com. Ziosoft Names Masao Yamamura as Chief Development OfficerRedwood City, CA, May 1, 2008 --- Masao Yamamura has been appointed Chief Development Officer (CDO) for Ziosoft, Inc., a leader in advanced visualization and analysis software for medical imaging. In his new position, Yamamura will be responsible for overseeing technology research and new product development across the entire global organization. Yamamura brings to the position over 25 years of research and development experience on networked digital imaging systems. He has a demonstrated track record of leading products from planning to development to commercialization. Most recently, he was Senior Vice President and GM at Electronics for Imaging (EFI). Prior to joining EFI, he developed workstations and printing systems for Fuji Xerox and Xerox Corporation. Masao Yamamura holds a BS and MS in Information System Engineering from Hiroshima University, Japan. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked volumetric medical imaging and analysis software to benefit physicians, patients, and healthcare specialists. Ziosoft is dedicated to providing advanced intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA and Tokyo, Japan. For more information, visit http://www.ziosoftinc.com. Ziosoft Names Richard Ball, Director of Regulatory and Quality AffairsRedwood City, CA, January 7, 2008 --- Richard Ball has been appointed Director of Regulatory and Quality Affairs for Ziosoft, Inc., a leader in advanced visualization and analysis software for medical imaging. Ball will direct and manage the Company's regulatory affairs strategy and be responsible for ensuring full compliance with all quality standards. Ball has more than 30 years in the medical device field with over 10 years of diverse experience as a regulatory affairs and quality assurance professional. Most recently, he was Director of Regulatory for Concentric Medical, Inc. Prior to Concentric, he held leadership positions for R2 Technology, Scientific Device Manufacturer, Abbott Labs, and Cordis. Richard Ball holds a BS with a major in Mechanical Engineering from Southern Methodist University and an MS in Biomedical Engineering from the University of Miami, Coral Gables. Ball is a member of the Regulatory Affairs Professionals Society, American Society for Quality (Biomedical Division), as well as the American Society of Plastics Engineering. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked volumetric medical imaging and analysis software to benefit physicians, patients, and healthcare specialists. As a medical imaging company dedicated to advanced intuitive clinical tools across the enterprise, Ziosoft is developing useful applications for automated physiological and disease recognition. Ziosoft is a privately held company headquartered in Tokyo, Japan and also has an office in Redwood City, CA. For more information, visit http://www.ziosoftinc.com. 2007Ziosoft's Preview for RSNA 2007Redwood City, CA, November 1, 2007 --- Ziosoft Inc., a leader in volumetric medical imaging software, will be showcasing the FDA-cleared ZIOSTATION 3D visualization and analysis software in booth 8951 at this year's RSNA in Chicago, IL. The ZIOSTATION provides advanced volumetric imaging tools to quickly access, analyze, and share the information required for the best patient care. Intelligent clinical tools include automatic segmentation, multi-data fusion, coronary analysis, and colon analysis. A customizable user-interface and flexible action macros further simplifies the user experience. The ZIOSTATION's full range of scalable configurations, from dedicated workstations to comprehensive server/thin client systems support critical functions for both physicians and technologists. With end-to-end product integration, every software and non-proprietary hardware component integrates efficiently. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked volumetric medical imaging and analysis software to benefit physicians, patients, and healthcare specialists. As a medical imaging company dedicated to advanced intuitive clinical tools across the enterprise, Ziosoft is developing useful applications for automated physiological and disease recognition. Ziosoft is a privately held company headquartered in Tokyo, Japan and also has an office in Redwood City, CA. For more information, visit http://www.ziosoftinc.com. Ziosoft Names Mark Koeniguer Senior Vice President of Business DevelopmentRedwood City, CA, October 16, 2007 --- Mark A. Koeniguer has been appointed Senior Vice President of Business Development for Ziosoft, Inc., a leader in advanced visualization and analysis software for medical imaging. In his new position, Koeniguer will plan and implement a distribution strategy for Ziosoft's thrust into the US market. Koeniguer brings to the position over 18 years of sales, marketing, and general management experience with both emerging and established companies in the healthcare industry. He has a demonstrated track record of building and leading high-performing teams, launching new products and services and improving market share. Most recently, he was Global Vice President of Sales for R2 Technology, Inc. prior to its acquisition by Hologic in 2006. Prior to joining R2, he held leadership positions for Stereotaxis, Inc. and GE Healthcare. Mark Koeniguer holds a BS with a major in Finance from the University of Iowa and an MBA from the University of Wisconsin – Madison. About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked volumetric medical imaging and analysis software to benefit physicians, patients, and healthcare specialists. As a medical imaging company dedicated to advanced intuitive clinical tools across the enterprise, Ziosoft is developing useful applications for automated physiological and disease recognition. Ziosoft is a privately held company headquartered in Tokyo, Japan and also has an office in Redwood City, CA. For more information, visit http://www.ziosoftinc.com. Ziosoft USA Announces Expansion and Relocation to New FacilityTokyo, Japan, February 11, 2007 --- Ziosoft Inc., a leader in volumetric medical imaging software, today announced the relocation of its US office to meet the rapid growth and future demands of its operations. The new, larger office is located at 2200 Bridge Parkway, Suite #103, Redwood City, CA. 94065. "We are excited to move into a new state-of-the-art facility," said Kazuhiko Matsumoto, Chief Executive Officer for Ziosoft. "In the past year we have doubled our staff in order to strengthen our focus and commitment to developing innovative advanced visualization tools for clinicians. This new space not only gives us room for continued growth, but we believe it will allow us to better serve our customers." About Ziosoft Inc.Ziosoft, Inc. is a recognized leader in networked volumetric medical imaging and analysis software to benefit physicians, patients, and healthcare specialists. As a medical imaging company dedicated to advanced intuitive clinical tools across the enterprise, Ziosoft is developing useful applications for automated physiological and disease recognition. Ziosoft is a privately held company headquartered in Tokyo, Japan and also has an office in Redwood City, CA. For more information, visit http://www.ziosoftinc.com. 2006Ziosoft's 3D Medical Imaging Software Showcased with Intel Japan's New Quad-Core ProcessorTokyo, Japan, November 20, 2006 --- Ziosoft Inc., a leader in 3D medical imaging software, was selected by Intel Japan as an application provider to showcase the performance of Intel's new Xeon 5300 series quad-core processor at the Imperial Hotel in Tokyo, Japan on November 15th, 2006. Intel Japan demonstrated its quad-core processor using the ZIOSTATION, Ziosoft's flagship 3D software installed on two PCs, one with a Xeon 5355 quad-core processor and the other with a Xeon 5160 dual-core processor. Quad-core processor showed a 70% improvement in speed compared with dual-core. In application-level software, a maximum of only 50% performance increase can usually be expected due to the technical difficulties of parallel processing. Ziosoft achieved with its ZIOSTATION, an unprecedented level of parallel processing based on its innovative technology. This capability enabled Ziosoft to utilize the full capacity of a greatly enhanced CPU, which was proven by the demonstration. "We are pleased that Ziosoft was selected by Intel Japan to demonstrate the capability of the new quad-core processor," said Kazuhiko Matsumoto, Chief Executive Officer for Ziosoft. "Few applications are so advanced as to utilize the full capability of the quad-core processor and this is a testimony to the leading edge technological achievement of Ziosoft." About Ziosoft Inc. ZIOSTATION (R) is a registered trademark of Ziosoft, Inc. Ziosoft disclaims any proprietary interest in the marks and names of others. ZioSoft Japan has received the 9001:2000 and ISO 13485:2003 CertificationsMarch 2006 --- Ziosoft Inc., the leading provider of 3D imaging software for medical applications in Japan, announces it has received the ISO 9001:2000 and ISO 13485:2003 Certifications. ISO 9001:2000 is an international standard on quality assurance and quality management aimed to achieve superior customer satisfaction. ISO 13485:2003 is another standard set forth by the ISO that compliments ISO 9001. It is a Quality Management System developed to harmonize with the requirements specific to medical devices. The standard strictly mandates wide range of procedures to be documented, including control of documents, control of records, control of nonconforming product, issue of advisory notice/adverse event reporting, and corrective action and preventive action. Acquiring these two certifications demonstrates that Ziosoft is meeting the highest quality assurance standards. Ziosoft is committed to provide the superior quality of products and services to its customers. |
|
| Copyright © 2010 Ziosoft, Inc. All rights reserved. | Privacy Policy | Copyright Statement | Contact Us | Site Map | Site Credits |